Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma

Y. Feshchenko, L. Iashyna, N. Kramarskaya, M. Polianska, J. Matvienko (Kiev, Ukraine)

Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Session: Asthma assessment and original therapeutic approaches
Session type: E-Communication Session
Number: 4554
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Feshchenko, L. Iashyna, N. Kramarskaya, M. Polianska, J. Matvienko (Kiev, Ukraine). Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 4554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009



Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Effectiveness of prolonged cholinolytic in complex basic therapy on the tolerability of physical load in severe bronchial asthma patients
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008

Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Clinical review of long-term pranlukast therapy in adult patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 310s
Year: 2004

Clinical and functional effectiveness of roflumilast in severe COPD patients
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013


Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005

Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001

Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Clinical and histological impact of omalizumab in oral corticosteroid-dependent severe allergic asthma
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019
Year: 2020



Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007

Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Advances of selenium add-on treatment in severe steroids-dependant bronchial asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Non-drug methods in complex treatment of the severe bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Assesment of long-term omalizumab treatment in severe allergic asthma
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012